DM
Insider
David C. Myles
CH. DISCOV. & NON-CLIN DEV OFFDavid C. Myles (CH. DISCOV. & NON-CLIN DEV OFF) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Olema Pharmaceuticals, Inc. (OLMA). The largest single filing was $3.1M of OLMA (109,800 sh across 4 lots, as filed), executed Jan 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.6M
shares × price, as filed
Last traded
Jan 14
Filed Jan 14
Median ADV $15.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
OLMA
Olema Pharmaceuticals, Inc.
OLMA · 0 buys · 3 sells
3 filings
Recent filings
OLMASALE
Olema Pharmaceuticals, Inc.
View filing →
$3.1M109,800 sh across 4 lots
Exec Jan 12
Filed Jan 14 · 5:30 PM ET OLMASALE Olema Pharmaceuticals, Inc. View filing → $1.5M
49,775 sh across 2 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET OLMASALE Olema Pharmaceuticals, Inc. View filing → $232K
25,766 sh across 2 lots
Exec Dec 10 2024
Filed Dec 11 2024 · 5:30 PM ET